Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
PAHC	PHIBRO ANIMAL HEALTH CORP	$1.24B	12.40%	2.80%	7.74%	5.90%	3.95	2.91	31.70%	2.70%	6.83%
EMBC	EMBECTA CORP	$810.60M	-7.00%	4.40%	19.34%	7.60%	-2.52	2.48	63.50%	4.90%	15.42%
TBPH	THERAVANCE BIOPHARMA INC	$651.68M	6.90%	3.50%	11.49%	15.90%	0.90	6.71	100.00%	16.90%	55.25%
AMRX	AMNEAL PHARMACEUTICALS INC	$2.95B	-3.00%	0.10%	12.55%	8.20%	-31.53	1.43	37.70%	0.10%	10.19%
TBRG	TRUBRIDGE INC	$287.47M	-5.80%	-2.50%	6.18%	9.80%	1.25	1.80	52.80%	-2.80%	6.04%
INDV	INDIVIOR PLC	$2.89B	-56.00%	8.90%	64.65%	78.00%	-6.65	0.90	84.00%	10.90%	21.81%
KMDA	KAMADA LTD	$419.79M	7.40%	5.20%	6.05%	15.50%	0.42	4.00	43.60%	11.20%	11.51%
GRFS	GRIFOLS SA	$7.38B	2.70%	0.70%	5.73%	5.80%	2.18	2.66	38.70%	2.20%	15.29%
EHAB	ENHABIT INC	$374.21M	-24.00%	-10.70%	-8.67%	-14.00%	1.22	1.49	49.00%	-13.40%	-9.19%
AUPH	AURINIA PHARMACEUTICALS INC	$1.59B	16.70%	11.50%	15.80%	14.50%	0.50	5.23	89.50%	23.30%	25.77%
RIGL	RIGEL PHARMACEUTICALS INC	$679.65M	438.90%	57.00%	88.99%	124.70%	1.52	2.02	91.50%	36.50%	39.89%
LIVN	LIVANOVA PLC	$2.96B	-17.70%	-8.40%	-7.27%	-13.90%	1.23	1.29	69.10%	-16.10%	-9.33%
HALO	HALOZYME THERAPEUTICS INC	$7.67B	136.60%	26.40%	36.99%	27.90%	5.17	8.36	84.20%	47.30%	60.25%
MD	PEDIATRIX MEDICAL GROUP INC	$1.35B	14.10%	5.30%	10.21%	18.50%	1.52	1.80	24.40%	5.70%	9.26%
NVST	ENVISTA HOLDINGS CORP	$3.46B	1.80%	1.00%	3.18%	7.10%	0.81	2.44	54.70%	2.10%	6.07%
ANIP	ANI PHARMACEUTICALS INC	$1.95B	-5.40%	-1.90%	-0.83%	-1.00%	2.03	2.66	59.30%	-3.40%	-1.35%
AVAH	AVEANNA HEALTHCARE HOLDINGS INC	$1.50B	-18.90%	1.10%	15.00%	13.30%	-148.62	1.09	33.30%	0.90%	9.35%
MDXG	MIMEDX GROUP INC	$1.06B	16.20%	12.00%	17.68%	40.40%	0.34	4.39	81.50%	8.80%	11.70%
STE	STERIS PLC	$24.24B	9.70%	6.30%	9.72%	17.30%	0.49	2.22	44.10%	11.60%	16.54%
INFU	INFUSYSTEM HOLDINGS INC	$194.66M	9.10%	4.90%	12.11%	9.60%	0.85	2.19	54.50%	3.60%	7.36%
TFX	TELEFLEX INC	$5.37B	4.50%	2.60%	4.92%	10.00%	0.74	2.41	55.60%	6.30%	10.78%
BMRN	BIOMARIN PHARMACEUTICAL INC	$11.14B	11.50%	9.20%	12.57%	15.10%	0.24	5.56	79.60%	21.50%	27.78%
ARDT	ARDENT HEALTH PARTNERS INC	$1.79B	22.30%	5.20%	9.43%	8.10%	2.70	2.13	18.30%	4.10%	6.31%
SIGA	SIGA TECHNOLOGIES INC	$614.38M	40.50%	35.60%	50.40%	194.00%	0.12	10.09	76.90%	45.70%	59.65%
NBIX	NEUROCRINE BIOSCIENCES INC	$13.02B	13.20%	9.40%	15.76%	15.90%	0.44	3.20	98.50%	13.90%	21.00%
ONC	BEONE MEDICINES LTD	$34.11B	-5.10%	-3.00%	-2.23%	-4.10%	0.67	1.95	85.50%	-3.90%	-1.99%
SNN	SMITH & NEPHEW PLC	$16.07B	7.70%	3.90%	7.03%	8.30%	0.93	3.00	69.60%	7.10%	11.07%
BVS	BIOVENTUS INC	$606.86M	-0.10%	0.00%	6.80%	8.10%	3.14	1.48	67.60%	0.00%	6.29%
KNSA	KINIKSA PHARMACEUTICALS INTERNATIONAL PLC	$2.47B	1.00%	0.80%	2.62%	4.30%	0.34	3.57	85.90%	0.90%	2.69%
COLL	COLLEGIUM PHARMACEUTICAL INC	$1.19B	19.20%	2.90%	12.45%	18.20%	5.96	1.08	57.70%	6.60%	21.45%
FONR	FONAR CORP	$99.91M	4.70%	3.70%	5.86%	6.70%	0.32	10.05	41.20%	7.70%	11.42%
THC	TENET HEALTHCARE CORP	$15.23B	37.30%	5.10%	11.81%	13.00%	5.44	1.71	100.00%	7.20%	13.95%
BCRX	BIOCRYST PHARMACEUTICALS INC	$1.77B	N/A	-7.40%	22.20%	6.00%	-2.08	2.25	97.00%	-6.40%	11.15%
INCY	INCYTE CORP	$16.82B	24.10%	15.80%	27.84%	62.90%	0.40	2.85	92.90%	19.00%	27.59%
NVS	NOVARTIS AG	$236.35B	32.60%	13.30%	23.01%	40.10%	1.49	0.82	76.20%	24.70%	30.30%
GRDN	GUARDIAN PHARMACY SERVICES INC	$1.51B	-61.50%	-26.90%	-36.56%	-60.30%	1.04	1.18	19.60%	-6.90%	-5.85%
XERS	XERIS BIOPHARMA HOLDINGS INC	$1.18B	N/A	-9.90%	-2.16%	-1.70%	-18.34	1.95	82.20%	-13.00%	-2.10%
AVDL	AVADEL PHARMACEUTICALS PLC	$1.31B	-3.70%	-1.70%	3.28%	4.70%	1.06	2.79	89.60%	-1.30%	1.93%
ALNY	ALNYLAM PHARMACEUTICALS INC	$58.03B	-274.20%	-7.40%	-6.96%	-4.50%	17.22	2.80	83.60%	-13.00%	-9.23%
SPOK	SPOK HOLDINGS INC	$379.49M	11.10%	8.10%	13.89%	43.90%	0.38	1.24	79.60%	12.10%	16.11%
SOLV	SOLVENTUM CORP	$12.66B	12.30%	2.60%	6.25%	7.10%	3.45	1.19	54.60%	4.60%	8.99%
IRWD	IRONWOOD PHARMACEUTICALS INC	$173.80M	N/A	-2.20%	70.34%	10.10%	-2.11	0.83	100.00%	-2.60%	25.18%
ELMD	ELECTROMED INC	$160.76M	16.50%	13.90%	21.86%	35.00%	0.19	5.19	77.60%	11.70%	15.64%
INVA	INNOVIVA INC	$1.32B	5.70%	3.00%	7.86%	9.00%	0.87	2.64	86.60%	10.40%	23.09%
CPIX	CUMBERLAND PHARMACEUTICALS INC	$44.73M	-12.80%	-4.40%	-5.98%	-9.20%	1.45	1.25	84.30%	-8.00%	-6.46%
VRTX	VERTEX PHARMACEUTICALS INC	$100.07B	22.10%	15.90%	22.07%	31.10%	0.40	2.52	86.10%	31.90%	38.45%
NAGE	NIAGEN BIOSCIENCE INC	$774.40M	35.50%	23.80%	26.49%	199.80%	0.43	3.88	63.60%	15.20%	15.76%
MIRM	MIRUM PHARMACEUTICALS INC	$3.26B	-24.80%	-8.50%	-7.40%	-10.50%	1.85	3.13	79.00%	-13.60%	-10.02%
BWAY	BRAINSWAY LTD	$241.37M	9.00%	5.70%	9.19%	51.50%	0.64	3.51	74.50%	11.60%	17.17%
BIIB	BIOGEN INC	$19.78B	9.00%	5.40%	7.15%	15.70%	0.61	2.50	75.40%	15.30%	17.98%
LLY	ELI LILLY & CO	$647.78B	88.40%	16.00%	27.24%	22.10%	4.52	1.28	82.60%	25.90%	31.66%
IRMD	IRADIMED CORP	$892.31M	23.30%	20.60%	26.67%	70.60%	0.13	8.78	77.00%	26.60%	33.54%
VTRS	VIATRIS INC	$12.46B	-19.90%	-8.50%	-10.40%	-14.20%	1.47	1.37	36.60%	-24.60%	-23.04%
CAH	CARDINAL HEALTH INC	$35.87B	-52.00%	3.20%	16.22%	36.00%	-20.05	0.94	3.70%	0.70%	1.04%
SHC	SOTERA HEALTH CO	$4.47B	5.80%	0.80%	8.77%	7.10%	6.48	2.46	55.20%	2.20%	22.75%
UHS	UNIVERSAL HEALTH SERVICES INC	$11.52B	18.00%	8.30%	13.82%	13.10%	1.18	1.32	41.80%	7.40%	10.78%
AMRN	AMARIN CORP PLC	$311.07M	-21.20%	-15.00%	-20.11%	-26.80%	0.44	3.26	37.50%	-47.20%	-44.38%
CRMD	CORMEDIX INC	$855.27M	22.60%	17.00%	14.95%	53.00%	0.30	4.21	95.20%	20.80%	20.85%
CRL	CHARLES RIVER LABORATORIES INTERNATIONAL INC	$7.67B	-2.00%	-0.90%	1.48%	1.70%	1.24	1.36	32.50%	-1.70%	2.38%
AXGN	AXOGEN INC	$685.59M	-4.40%	-2.30%	1.81%	1.50%	0.83	4.14	74.30%	-2.30%	1.60%
MMSI	MERIT MEDICAL SYSTEMS INC	$5.05B	8.50%	4.80%	7.62%	10.10%	0.74	4.09	47.90%	8.30%	12.56%
TCMD	TACTILE SYSTEMS TECHNOLOGY INC	$275.98M	7.30%	5.30%	10.14%	17.90%	0.40	3.79	74.70%	5.10%	7.90%
EW	EDWARDS LIFESCIENCES CORP	$45.90B	41.30%	31.60%	36.31%	71.50%	0.27	4.68	78.90%	73.00%	77.18%
AZN	ASTRAZENECA PLC	$243.26B	19.80%	7.80%	14.82%	26.20%	1.51	0.86	81.40%	14.70%	20.68%
OMCL	OMNICELL INC	$1.45B	1.80%	1.10%	1.00%	2.70%	0.70	1.42	43.70%	2.00%	1.34%
OPRX	OPTIMIZERX CORP	$325.33M	-13.10%	-9.10%	-6.83%	-19.20%	0.44	2.82	64.10%	-16.30%	-10.81%
PBYI	PUMA BIOTECHNOLOGY INC	$264.07M	49.30%	18.20%	39.47%	61.20%	1.02	1.53	72.40%	16.40%	18.58%
DH	DEFINITIVE HEALTHCARE CORP	$541.43M	-77.30%	-31.70%	-52.05%	-106.80%	1.18	1.65	76.40%	-124.40%	-131.52%
EHC	ENCOMPASS HEALTH CORP	$12.05B	30.70%	9.80%	15.98%	14.00%	1.62	1.06	26.50%	11.50%	16.69%
IDXX	IDEXX LABORATORIES INC	$52.32B	64.40%	29.90%	59.89%	50.70%	1.28	1.11	61.50%	24.40%	31.25%
MASI	MASIMO CORP	$8.25B	-40.80%	-17.60%	-24.18%	-21.70%	1.30	2.15	52.80%	-24.80%	-23.69%
WAY	WAYSTAR HOLDING CORP	$6.19B	2.80%	1.90%	4.65%	14.50%	0.47	3.43	67.30%	8.50%	20.80%
PODD	INSULET CORP	$22.23B	18.40%	7.20%	13.03%	11.10%	1.37	2.26	70.70%	10.00%	13.58%
ADUS	ADDUS HOMECARE CORP	$2.10B	8.40%	6.20%	9.68%	45.50%	0.38	1.74	32.60%	6.50%	9.56%
GSK	GSK PLC	$79.70B	24.20%	5.80%	12.18%	16.10%	3.04	0.87	71.40%	10.80%	14.97%
HCA	HCA HEALTHCARE INC	$92.11B	-189.60%	10.00%	23.00%	12.80%	-13.83	0.98	40.90%	8.20%	13.79%
BTSG	BRIGHTSPRING HEALTH SERVICES INC	$4.00B	3.90%	1.10%	6.23%	6.90%	2.41	1.76	12.90%	0.50%	2.31%
HCSG	HEALTHCARE SERVICES GROUP INC	$1.09B	2.20%	1.30%	3.26%	4.00%	0.68	2.49	10.90%	0.60%	1.08%
ELAN	ELANCO ANIMAL HEALTH INC	$8.94B	6.70%	3.30%	6.36%	10.60%	1.03	2.60	54.70%	9.70%	17.51%
VMD	VIEMED HEALTHCARE INC	$267.23M	10.50%	7.90%	14.12%	21.00%	0.31	1.48	58.30%	5.80%	8.63%
PGNY	PROGYNY INC	$1.93B	11.80%	7.80%	17.52%	24.70%	0.56	2.39	22.00%	4.30%	7.12%
BSX	BOSTON SCIENTIFIC CORP	$154.32B	11.50%	6.30%	9.18%	16.10%	0.84	1.37	68.30%	13.50%	18.05%
DXCM	DEXCOM INC	$31.36B	25.60%	8.50%	19.99%	14.40%	1.85	1.52	58.80%	13.30%	18.67%
NHC	NATIONAL HEALTHCARE CORP	$1.65B	11.00%	7.20%	11.48%	13.30%	0.54	1.90	100.00%	7.80%	10.87%
GILD	GILEAD SCIENCES INC	$147.68B	32.90%	11.20%	18.42%	23.70%	1.84	1.32	78.50%	21.90%	28.42%
AKBA	AKEBIA THERAPEUTICS INC	$864.07M	N/A	-18.90%	-9.98%	-30.20%	11.62	2.23	68.00%	-24.50%	-11.82%
ZYME	ZYMEWORKS INC	$996.47M	-31.60%	-24.00%	-29.74%	-33.70%	0.31	4.71	100.00%	-121.70%	-114.77%
FMS	FRESENIUS MEDICAL CARE AG	$14.59B	4.70%	2.00%	5.33%	5.90%	1.28	1.44	24.70%	3.40%	7.00%
RPRX	ROYALTY PHARMA PLC	$21.29B	10.20%	5.70%	7.52%	5.50%	0.93	1.26	100.00%	44.30%	55.83%
BMY	BRISTOL MYERS SQUIBB CO	$97.31B	29.60%	5.40%	9.80%	10.50%	4.43	1.21	70.30%	10.60%	13.79%
SNWV	SANUWAVE HEALTH INC	$323.23M	N/A	-125.30%	125.29%	108.30%	-2.78	0.40	76.60%	-89.90%	-56.82%
GMAB	GENMAB A	$14.74B	24.70%	19.90%	30.06%	75.00%	0.22	6.22	94.40%	37.60%	52.88%
VEEV	VEEVA SYSTEMS INC	$44.94B	13.70%	11.20%	16.03%	25.10%	0.25	4.61	75.50%	27.30%	35.42%
OPCH	OPTION CARE HEALTH INC	$4.61B	15.20%	6.20%	12.95%	17.40%	1.49	1.52	19.70%	3.90%	6.29%
LGND	LIGAND PHARMACEUTICALS INC	$3.01B	-9.20%	-8.10%	-9.15%	-17.30%	0.15	5.45	93.00%	-40.40%	-43.10%
ABBV	ABBVIE INC	$361.58B	142.10%	2.70%	5.67%	8.40%	-750.38	0.74	70.90%	6.50%	9.48%
LH	LABCORP HOLDINGS INC	$22.54B	9.30%	4.20%	7.82%	10.60%	1.13	1.50	28.10%	5.70%	8.90%
PCRX	PACIRA BIOSCIENCES INC	$1.12B	-16.50%	-8.20%	-7.18%	-7.60%	1.03	2.38	78.20%	-18.10%	-12.45%
SYK	STRYKER CORP	$144.71B	14.10%	6.50%	8.58%	12.50%	1.19	1.78	64.10%	12.30%	14.07%
TEVA	TEVA PHARMACEUTICAL INDUSTRIES LTD	$20.12B	-2.60%	-0.40%	3.19%	4.00%	4.88	1.06	49.60%	-1.00%	5.42%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	637	+0.16%	+4.39%	+5.40%	-64.07%	-116.18x	4.42x	-121.17%	-6.90%	-1.45%	+91.91%	Strong Buy
Diagnostics & Research	57	-0.65%	+5.82%	+10.75%	-11.64%	23.48x	3.84x	-3.66%	+7.34%	+14.22%	+6.42%	Buy
Drug Manufacturers - General	18	+1.22%	+4.73%	-2.89%	-13.96%	34.55x	5.87x	+58.71%	+10.34%	+17.79%	+52.31%	Buy
Drug Manufacturers - Specialty & Generic	77	+0.28%	+7.01%	+1.44%	-66.95%	-10.62x	2.24x	+12.23%	+4.91%	+10.43%	+33.61%	Buy
Healthcare Plans	11	+0.15%	+7.00%	-6.09%	-38.26%	13.12x	1.76x	+15.36%	+4.82%	+11.26%	+25.76%	Buy
Health Information Services	55	-0.70%	+5.29%	+3.12%	-55.42%	80.97x	4.02x	+7.39%	+4.83%	+9.55%	+21.87%	Strong Buy
Medical Care Facilities	48	-0.63%	+4.80%	+0.49%	-32.55%	15.89x	4.70x	-194.08%	+6.86%	+15.22%	+19.15%	Buy
Medical Devices	141	-0.80%	+4.06%	-1.62%	-20.79%	31.59x	3.98x	+13.01%	+8.47%	+10.00%	+30.11%	Strong Buy
Medical Distribution	10	+1.29%	+2.12%	-4.82%	+20.45%	26.65x	289.07x	-6.50%	+3.03%	+18.71%	+15.90%	Buy
Medical Instruments & Supplies	55	-1.07%	+2.00%	+0.19%	-60.20%	32.98x	3.50x	+10.58%	+8.31%	+11.13%	+23.54%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Aug 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Phibro Animal Health (NASDAQ:PAHC)

Phibro Animal Health (NASDAQ:PAHC) is the #1 top healthcare stock out of 1109 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Phibro Animal Health (NASDAQ:PAHC) is: Value: A, Growth: A, Momentum: B, Sentiment: A, Safety: B, Financials: C, and AI: B.

Phibro Animal Health (NASDAQ:PAHC) has a Due Diligence Score of 45, which is 20 points higher than the healthcare sector average of 25. It passed 16 out of 38 due diligence checks and has strong fundamentals. Phibro Animal Health has seen its stock return 75.79% over the past year, overperforming other healthcare stocks by 124 percentage points.

Phibro Animal Health has an average 1 year price target of $30.50, a downside of -0.23% from Phibro Animal Health's current stock price of $30.57.

Phibro Animal Health stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Phibro Animal Health, 50% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the #2 top healthcare stock out of 1109 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Embecta (NASDAQ:EMBC) is: Value: A, Growth: A, Momentum: D, Sentiment: B, Safety: D, Financials: A, and AI: A.

Embecta (NASDAQ:EMBC) has a Due Diligence Score of 31, which is 6 points higher than the healthcare sector average of 25. It passed 11 out of 38 due diligence checks and has average fundamentals. Embecta has seen its stock lose -5.97% over the past year, overperforming other healthcare stocks by 42 percentage points.

Embecta has an average 1 year price target of $12.00, a downside of -13.48% from Embecta's current stock price of $13.87.

Embecta stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Embecta, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Theravance Biopharma (NASDAQ:TBPH)

Theravance Biopharma (NASDAQ:TBPH) is the #3 top healthcare stock out of 1109 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Theravance Biopharma (NASDAQ:TBPH) is: Value: B, Growth: A, Momentum: C, Sentiment: B, Safety: D, Financials: A, and AI: C.

Theravance Biopharma (NASDAQ:TBPH) has a Due Diligence Score of 39, which is 14 points higher than the healthcare sector average of 25. It passed 12 out of 33 due diligence checks and has average fundamentals. Theravance Biopharma has seen its stock return 58.19% over the past year, overperforming other healthcare stocks by 106 percentage points.

Theravance Biopharma has an average 1 year price target of $21.33, an upside of 64.86% from Theravance Biopharma's current stock price of $12.94.

Theravance Biopharma stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Theravance Biopharma, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 71 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Simulations Plus (NASDAQ:SLP)

Simulations Plus (NASDAQ:SLP) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 2%. Simulations Plus's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Simulations Plus's dividend has shown consistent growth over the last 10 years.

Simulations Plus's dividend payout ratio of -1.9% indicates that its dividend yield might not be sustainable for the long-term.

2. Dr Reddys Laboratories (NYSE:RDY)

Dr Reddys Laboratories (NYSE:RDY) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 2%. Dr Reddys Laboratories's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Dr Reddys Laboratories's dividend has shown consistent growth over the last 10 years.

Dr Reddys Laboratories's dividend payout ratio of 12.2% indicates that its dividend yield is sustainable for the long-term.

3. Select Medical Holdings (NYSE:SEM)

Select Medical Holdings (NYSE:SEM) has an annual dividend yield of 14.1%, which is 12 percentage points higher than the healthcare sector average of 2%. Select Medical Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Select Medical Holdings's dividend has not shown consistent growth over the last 10 years.

Select Medical Holdings's dividend payout ratio of 35.1% indicates that its high dividend yield is sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.19% in the last day, and up 4.59% over the last week. Leap Therapeutics was the among the top losers in the healthcare sector, dropping -28.02% yesterday.

Leap Therapeutics shares are trading lower after the company reported a Q2 EPS miss.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 57, which is 41 points higher than the healthcare sector average of 16. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has dropped -5.97% in the past year. It has overperformed other stocks in the healthcare sector by 42 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 57, which is 41 points higher than the healthcare sector average of 16. It passed 4 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 5.98% in the past year. It has overperformed other stocks in the healthcare sector by 54 percentage points.

3. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 27 points higher than the healthcare sector average of 16. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 95.95% in the past year. It has overperformed other stocks in the healthcare sector by 144 percentage points.

Are healthcare stocks a good buy now?

50.6% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 44.32% over the next year.

5.45% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.32% of healthcare stocks are rated B (Buy), 42.3% are rated C (Hold), 26.54% are rated D (Sell), and 13.39% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 7.22x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Phibro Animal Health (NASDAQ:PAHC)

2. Embecta (NASDAQ:EMBC)

3. Theravance Biopharma (NASDAQ:TBPH)

1. Simulations Plus (NASDAQ:SLP)

2. Dr Reddys Laboratories (NYSE:RDY)

3. Select Medical Holdings (NYSE:SEM)

1. Embecta (NASDAQ:EMBC)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Puma Biotechnology (NASDAQ:PBYI)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2025)Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Phibro Animal Health (NASDAQ:PAHC)

2. Embecta (NASDAQ:EMBC)

3. Theravance Biopharma (NASDAQ:TBPH)

1. Simulations Plus (NASDAQ:SLP)

2. Dr Reddys Laboratories (NYSE:RDY)

3. Select Medical Holdings (NYSE:SEM)

1. Embecta (NASDAQ:EMBC)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Puma Biotechnology (NASDAQ:PBYI)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.